drugset / Trial / NCT02776371
Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori
RandomizedParallel-groupOpen-labelTreatment
Summary
Helicobacter pylori (H. pylori) infects more than 50% of the population in the world(1), especially 47-66% in China.
Timeline
- Start
- 2016-09
- Primary completion
- 2018-01
- Completion
- 2018-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1 g | — |
| Comparator | Clarithromycin | Small molecule | 500 mg | — |
| Subject | tinidazole | Small molecule | 500 mg | — |
| Background | Rabeprazole | Small molecule | 10 mg | — |
Indications
No indication recorded.